Вплив мезенхімальних стовбурових клітин на пухлинні клітини раку молочної залози при безконтактному спів-культивуванні
DOI :
https://doi.org/10.15587/2313-8416.2015.51365Mots-clés :
мезенхімальні стовбурові клітини, естрогеновий рецептор, рецептор ЕФР, цитокератин, Е-кадхеринRésumé
В данній роботі було визначено кінетичні параметри росту пухлинних клітин людини (MCF-7) in vitro при спів-культивуванні з МСКл, оцінено рівень експресії деяких онкогенних маркерів пухлинними клітинами (естрогенового рецептору, рецептору епідермального фактору росту, цитокератинів та Е-кадхеріну) під впливом МСКл та проведено порівняльний аналіз вищезазначених параметрів при різних строках культивування в суспензивній та адгезивній фракціях культури
Références
Ivaniyk, D. I., Turchin, V. V., Popandopyla, А. G. et. al (2011). Мehanizmu immunomoduliryyschego deystvia mesenhimalnuh stvolovuh kletok [The mechanisms of immunomodulatory effects of mesenchymal stem cells]. Transplantatologiya Cell and Tissue Engineering, 2, 27–33.
Кalinina, N. I., Susoeva, E. Yu., Rubina, K. A. et. al (2010). Mesenhimalnue stvolovue kletki v processah rosta i reparacii tkaney [Mesenchymal stem cells in the growth and repair of tissues]. Acta Naturae, 4 (11), 32–39.
Lusianuy N.I. (2013). Mesenhimalnue stvolovue kletki i cancerogenez [mesenchymal stem cells and carcinogenesis]. Оncology, 1, 4–8.
Betancourt, A. M., Waterman, R. S. (2012). The Role of Mesenchymal Stem Cells in the Tumor Microenvironment. Tumor Microenvironment and Myelomonocytic Cells. New Orleans, Louisiana, USA, 298. doi: 10.5772/31933
Gomes С. (2013). The dual role of mesenchymal stem cells in tumor progression. Stem Cell Research & Therapy, 4 (42), 1206–1217. doi: 10.1186/scrt189
Kéramidas, M., de Fraipont, F., Karageorgis, A. et. al (2013). The dual effect of mscs on tumour growth and tumour angiogenesis. Stem Cell Research & Therapy, 4 (2), 41. doi: 10.1186/scrt195
Zheng, P.-X., Zhou, H., Tan, J.-M. (2013). Impact of mesenchymal stem cells on the proliferation, invasion and biological behaviors of hepatocellular carcinoma cells. Chinese Journal of Tissue Engineering Research, 17 (36), 6521–6526.
Zwaginga, J., Doevendans, P. (2003). Stem cell-derived angiogenic/vasculogenic cells: Possible therapies for tissue repair and tissue engineering. Clinical and Experimental Pharmacology and Physiology, 30 (11), 900–908. doi: 10.1046/j.1440-1681.2003.03931.x
Chamberlain, G., Fox, J., Ashton, B., Middleton, J. (2007). Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing. Stem Cells, 25 (11), 2739–2749. doi: 10.1634/stemcells.2007-0197
Krampera, M., Pasini, A., Pizzolo, G., Cosmi, L., Romagnani, S., Annunziato, F. (2006). Regenerative and immunomodulatory potential of mesenchymal stem cells. Current Opinion in Pharmacology, 6 (4), 435–441. doi: 10.1016/j.coph.2006.02.008
Toubai, T., Paczesny, S., Shono, Y., Tanaka, J., Lowler, K., Malter, C. et. al (2009). Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus- Host Disease After Allogeneic Hematopoietic Cell Transplantation. Current Stem Cell Research & Therapy, 4 (4), 252–259. doi: 10.2174/157488809789649269
Ferrantini, M., Capone, I., Belardelli, F. (2007). Interferon-α and cancer: Mechanisms of action and new perspectives of clinical use. Biochimie, 89 (6-7), 884–893. doi: 10.1016/j.biochi.2007.04.006
Rizza, P., Morettia, F., Belardelli, F. (2010). Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity. Autoimmunity, 43 (3), 204–209. doi: 10.3109/08916930903510880
Suzdaltseva, Yu. G., Rubtsov, Yu. P. (2011). Vliyanee mesenhimalnuh stvolovuh kletok zshorovoy tkani na aktivatciyu limfotcitov perefericheskoy krovi in vitro [Influence of mesenchymal stem cells of adipose tissue on the activation of peripheral blood lymphocytes in vitro]. Stem cells and regenerative medicine, 4, 73–74.
Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., Epstein, S. E. (2004). Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms. Circulation Research, 94 (5), 678–685. doi: 10.1161/01.res.0000118601.37875.ac
Plotnicov, E. Yu., Zorov, D. B., Suhih, G. T. (2009). Stvolovue kletki v regenerativnoy terapii serdechnuh zabo;ovaniy: rol' mezshkletochnuch vzaimodeystviy [Stem cells in regenerative therapy for heart disease: the role of cell-cell interactions]. Stem cells and regenerative medicine, 1, 43–49.
Bernardo, M. E., Zaffaroni, N., Novara, F., Cometa, A. M., Avanzini, M. A., Moretta, A. et. al (2007). Human Bone Marrow Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term In vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms. Cancer Research, 67 (19), 9142–9149. doi: 10.1158/0008-5472.can-06-4690
Han, X., Meng, X., Yin, Z., Rogers, A., Zhong, J., Rillema, P. et. al (2009). Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle, 8 (4), 606–610. doi: 10.4161/cc.8.4.7731
Hida, N., Nishiyama, N., Miyoshi, S., Kira, S., Segawa, K., Uyama, T. et. al (2008). Novel Cardiac Precursor-Like Cells from Human Menstrual Blood-Derived Mesenchymal Cells. Stem Cells, 26 (7), 1695–1704. doi: 10.1634/stemcells.2007-0826
Motaln, H., Schichor, C., Lah, T. T. (2010). Human mesenchymal stem cells and their use in cell-based therapies. Cancer, 116 (11), 2519–2530. doi: 10.1002/cncr.25056
Salem, K., Thiemermann, C. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 28 (3), 585–596. doi: 10.1002/stem.269
Wang, S., Qu, X., Zhao, R. (2012). Clinical applications of mesenchymal stem cells. Journal of Hematology & Oncology, 5 (1), 19. doi: 10.1186/1756-8722-5-19
Wolff, E. F., Gao, X.-B., Yao, K. V., Andrews, Z. B., Du, H., Elsworth, J. D., Taylor, H. S. (2011). Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model. Journal of Cellular and Molecular Medicine, 15 (4), 747–755. doi: 10.1111/j.1582-4934.2010.01068.xx
Honoki, K. (2011). Cancer Stem Cell Nich: Stem cells in tumor microenvironment. Cancer stem cells-the cuttinged edge, 10 (121), 189–203.
On claims of order of conducting preclinical study of medications and examinations of materials of preclinical study of medications: Order of Ministry of Health of Ukraine (2009). 14.12.09., 944. Available at: http://zakon.Rada.Gov.Ua/clibin/laws/mains.cgi?nreg=z0053-10/
Thomas, C., Gustafsson, J.-Å. (2011). The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer, 11 (8), 597–608. doi: 10.1038/nrc3093
Jazieh, A. R, Kyasa, M. J., Hutchins, L. (2004). Phase I clinical trial of tamoxifen and interferon alpha in the treatment of solid tumors. Journ. Appl. Res., 4, 464–469.
Suo, Z., Risberg, B., Karlsson, M. G., Villman, K., Skovlund, E., Nesland, J. M. (2002). The Expression of EGFR Family Ligands in Breast Carcinomas. International Journal of Surgical Pathology, 10 (2), 91–99. doi: 10.1177/106689690201000202
Lewis-Wambi, J. S., Jordan, V. C. (2009). Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Research, 11 (3), 206. doi: 10.1186/bcr2255
Woodburn, J. (1999). The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy. Pharmacology & Therapeutics, 82 (2-3), 241–250. doi: 10.1016/s0163-7258(98)00045-x
Saha Roy, S., Vadlamudi, R. K. (2012). Role of Estrogen Receptor Signaling in Breast Cancer Metastasis. International Journal of Breast Cancer, 2012, 1–8. doi: 10.1155/2012/654698
Thomas, C., Gustafsson, J.-Å. (2011). The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer, 11 (8), 597–608. doi: 10.1038/nrc3093
Cavallaro, U., Schaffhauser, B., Christofori, G. (2002). Cadherins and the tumour progression: is it all in a switch? Cancer Letters, 176 (2), 123–128. doi: 10.1016/s0304-3835(01)00759-5
Téléchargements
Publié-e
Numéro
Rubrique
Licence
(c) Tous droits réservés Олена Вікторівна Ястребова, Олена Михайлівна Перепелиціна, Сергій Васильович Безуглий, Михайло Васильович Сидоренко 2015
Cette œuvre est sous licence Creative Commons Attribution 4.0 International.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
